Addyi Side Effects
Generic Name: flibanserin
Medically reviewed by Drugs.com. Last updated on March 29, 2020.
Note: This document contains side effect information about flibanserin. Some of the dosage forms listed on this page may not apply to the brand name Addyi.
Common side effects of Addyi include: syncope, central nervous system depression, dizziness, drowsiness, fatigue, nausea, sedated state, and hypotension. Other side effects include: insomnia. See below for a comprehensive list of adverse effects.
For the Consumer
Applies to flibanserin: oral tablet
Oral route (Tablet)
The use of flibanserin and alcohol together close in time increases the risk of severe hypotension and syncope. Counsel patients to wait at least 2 hours after consuming 1 or 2 standard alcoholic drinks before taking flibanserin at bedtime or to skip their bedtime flibanserin dose if they have consumed 3 or more standard alcoholic drinks that evening. Flibanserin is contraindicated with moderate or strong CYP3A4 inhibitors and in patients with hepatic impairment due to risk of severe hypotension and syncope.
Side effects requiring immediate medical attention
Along with its needed effects, flibanserin (the active ingredient contained in Addyi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking flibanserin:
- Blurred vision
- dizziness, fainting, or lightheadedness, especially when getting up suddenly from a lying or sitting position
- sleepiness or unusual drowsiness
- unusual tiredness or weakness
- Feeling of constant movement of self or surroundings
- sensation of spinning
Side effects not requiring immediate medical attention
Some side effects of flibanserin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- dry mouth
- normal menstrual bleeding occurring earlier, possibly lasting longer than expected
- trouble sleeping
For Healthcare Professionals
Applies to flibanserin: oral tablet
When this drug is used alone, the incidence of hypotension is 0.2% and syncope is 0.4%. When this drug is taken with 0.4 g/kg alcohol, 17% had substantial reductions in blood pressure, resulting in hypotension and/or syncope requiring medical intervention. When 0.8 g/kg alcohol was taken in combination with this drug, 25% experienced orthostatic hypotension.[Ref]
Uncommon (0.1% to 1%): Hypotension, syncope[Ref]
Very common (10% or more): Dizziness (11.4%), somnolence (11.2%)
-Serious adverse reactions were reported in 0.9% of patients. The discontinuation rate due to adverse reactions was 13%. The most common adverse reactions leading to discontinuation were dizziness, nausea, insomnia, somnolence, and anxiety.
-The majority of adverse reactions began within the first 14 days of treatment.[Ref]
Common (1% to 10%): Accidental injury[Ref]
Common (1% to 10%): Insomnia, anxiety[Ref]
Very common (10% or more): Nausea (10.4%)
Common (1% to 10%): Dry mouth, constipation
Uncommon (0.1% to 1%): Appendicitis[Ref]
Common (1% to 10%): Metrorrhagia[Ref]
Common (1% to 10%): Abdominal pain[Ref]
Common (1% to 10%): Rash[Ref]
1. "Product Information. Addyi (flibanserin)." Sprout Pharmaceuticals, Raleigh, NC.
Frequently asked questions
More about Addyi (flibanserin)
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 38 Reviews
- Drug class: miscellaneous central nervous system agents
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.